Sign in

CIK 0000874716

  • Large accelerated filer

IDEXX LABORATORIES INC /DE

Sign in to watch
Ticker
IDXX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010393723
Phone
+1 207-556-0300
Business address
ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
  1. 4 Exercise or conversion Executive VP & CFO acquired 706 shares (option exercise)
  2. 4 Open-market sale Director sold 250 shares at $509.70 ($127,425)
  3. 4 Shares withheld for taxes EVP, GC & Corp. Secretary gave up 253 shares (to pay taxes)
  4. 4 Shares withheld for taxes Senior Vice President gave up 252 shares (to pay taxes)
  5. 4 Shares withheld for taxes Senior Vice President gave up 295 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Shares withheld for taxes Executive Vice President gave up 235 shares (to pay taxes)
  8. 4 Shares withheld for taxes Executive VP & CFO gave up 964 shares (to pay taxes)
  9. 4 Shares withheld for taxes President & CEO gave up 1,423 shares (to pay taxes)
  10. 4 Shares withheld for taxes Executive Vice President gave up 1 shares (to pay taxes)
  11. 4 Shares withheld for taxes Executive Vice President gave up 204 shares (to pay taxes)
  12. 4 Gift Director gave 660 shares (gift)
  13. 4 Grant or award Director acquired 13 shares (grant or award)
  14. 4 Grant or award Director acquired 49 shares (grant or award)
  15. 4 Grant or award Director acquired 41 shares (grant or award)
  16. 5 Insider Annual Insider Trading Report
  17. 4 Open-market sale Executive Vice President sold 4,595 shares at $633.00 ($2,908,635)
  18. 4 Gift Director gave 1,560 shares (gift)
  19. 4 Open-market sale Executive VP & CFO sold 9,225 shares at an average $620.73 ($5,726,188)
  20. 4 Open-market sale Executive VP & CFO sold 20,000 shares at an average $624.96 ($12,499,279)

Page 13 of 74 · 1,467 filings